Edition:
United Kingdom

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

87.34USD
16 Aug 2019
Change (% chg)

$1.37 (+1.59%)
Prev Close
$85.97
Open
$86.15
Day's High
$87.88
Day's Low
$86.00
Volume
242,552
Avg. Vol
336,485
52-wk High
$94.84
52-wk Low
$69.36

Latest Key Developments (Source: Significant Developments)

McKesson, Cardinal, Amerisourcebergen Propose Paying $10 Bln To Settle Claims They Helped Fuel Opioid Epidemic - Bloomberg
Tuesday, 6 Aug 2019 

Aug 6 (Reuters) - :DRUG DISTRIBUTORS MCKESSON, CARDINAL, AMERISOURCEBERGEN PROPOSE PAYING $10 BILLION TO SETTLE CLAIMS THEY HELPED FUEL OPIOID EPIDEMIC - BLOOMBERG REPORTER TWEET.  Full Article

PharMEDium Services Issues Voluntary Nationwide Recall
Tuesday, 2 Jul 2019 

July 2 (Reuters) - AmerisourceBergen Corp ::PHARMEDIUM SERVICES, LLC ISSUES VOLUNTARY NATIONWIDE RECALL OF 0.5 MG/ML HYDROMORPHONE HCL IN 0.9% SODIUM CHLORIDE 1 ML IN 3 ML BD SYRINGE DUE TO PRESENCE OF SULFITE.PHARMEDIUM SERVICES - VOLUNTARILY RECALLING 45 LOTS OF 0.5 MG/ML HYDROMORPHONE HCL IN 0.9% SODIUM CHLORIDE 1 ML IN 3 ML BD SYRINGE TO THE USER LEVEL.  Full Article

Federal Judge Enters Consent Decree Against Compounder Pharmedium Services For Violations At Multiple Facilities
Wednesday, 22 May 2019 

May 22 (Reuters) - U.S. Food and Drug Administration::FEDERAL JUDGE ENTERS CONSENT DECREE AGAINST COMPOUNDER PHARMEDIUM SERVICES FOR VIOLATIONS AT MULTIPLE FACILITIES.FDA - CONSENT DECREE PROHIBITS PHARMEDIUM FROM MANUFACTURING DRUGS AT TENNESSEE FACILITY UNTIL IT COMPLETES CORRECTIVE ACTIONS, RECEIVES FDA AUTHORIZATION.  Full Article

AmerisourceBergen Q1 Adjusted Earnings Per Share $1.60
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2019 FIRST QUARTER RESULTS.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $6.65 TO $6.85.Q1 ADJUSTED EARNINGS PER SHARE $1.60.Q1 GAAP EARNINGS PER SHARE $1.84.Q1 EARNINGS PER SHARE ESTIMATE $1.50 -- REFINITIV IBES DATA.ADJUSTED DILUTED EPS GUIDANCE NARROWED TO $6.65 TO $6.85 FOR FISCAL 2019.REVENUES OF $45.4 BILLION FOR Q1, A 12.2 PERCENT INCREASE YEAR-OVER-YEAR.Q1 REVENUE VIEW $43.84 BILLION -- REFINITIV IBES DATA.AMERISOURCEBERGEN -SEES FISCAL YEAR 2019 ADJUSTED OPERATING INCOME GROWTH IN LOW-SINGLE DIGIT PERCENT RANGE, DOWN FROM LOW- TO MID-SINGLE DIGIT PERCENT RANGE.AMERISOURCEBERGEN-UPDATED 2019 FINANCIAL GUIDANCE ON EVALUATION OF EXPECTATIONS AT PHARMEDIUM ON ASSUMPTION THAT MEMPHIS FACILITY TO NOT REOPEN THIS FISCAL YEAR.UPDATED FISCAL YEAR 2019 GUIDANCE INCORPORATES HIGHER THAN ANTICIPATED LEVEL OF SHARE REPURCHASES IN Q1 OF FISCAL YEAR.  Full Article

Amerisourcebergen Names James Cleary, Jr. As CFO
Monday, 10 Sep 2018 

Sept 10 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN ANNOUNCES FINANCIAL LEADERSHIP CHANGE.CFO TIM G. GUTTMAN TO RETIRE FROM COMPANY.GROUP PRESIDENT JAMES F. CLEARY, JR. NAMED CFO.COMPANY REAFFIRMS FISCAL YEAR 2018 GUIDANCE.AMERISOURCEBERGEN - GUTTMAN WILL STEP DOWN AS CFO ON NOVEMBER 9 AND CONTINUE IN AN ADVISORY CAPACITY FURTHER INTO FISCAL YEAR 2019.FY2018 EARNINGS PER SHARE VIEW $6.48, REVENUE VIEW $167.99 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Amerisourcebergen Provides Update On Unit Pharmedium's 503B Compounding Facility In Memphis, Tennessee
Wednesday, 5 Sep 2018 

Sept 5 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN SAYS PROVIDES UPDATE REGARDING SUBSIDIARY PHARMEDIUM'S 503B COMPOUNDING FACILITY LOCATED IN MEMPHIS, TENNESSEE.AMERISOURCEBERGEN SAYS THIRD-PARTY CURRENT GOOD MANUFACTURING PRACTICES EXPERTS' MEMPHIS FACILITY AUDIT REPORT WAS SUBMITTED TO FDA ON SEPT. 5 - SEC FILING.AMERISOURCEBERGEN - PHARMEDIUM IS SCHEDULED TO SUBMIT ITS EVALUATION OF THE AUDIT REPORT AND ITS PLANNED ACTIONS WITH RESPECT THERETO ON SEPT. 6.AMERISOURCEBERGEN - PHARMEDIUM TO CONTINUE LIMITED PRODUCTION &,ABSENT FURTHER FEEDBACK FROM FDA, EXPECTS TO COMMENCE COMMERCIAL DISTRIBUTION IN 2018.AMERISOURCEBERGEN - ALL PREVIOUSLY COMMUNICATED ASPECTS OF CO'S FISCAL YEAR 2018 FINANCIAL GUIDANCE & ASSUMPTIONS REMAIN THE SAME.FY2018 EARNINGS PER SHARE VIEW $6.48, REVENUE VIEW $168.01 BILLION -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - AFTER RESUMING COMMERCIAL DISTRIBUTION, CONTINUES TO EXPECT PRODUCTION IN MEMPHIS TO BE FULLY OPERATIONAL IN 2019.  Full Article

AmerisourceBergen Reports Fiscal Q3 Results
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 THIRD QUARTER RESULTS.REVENUES OF $43.1 BILLION FOR Q3, AN 11.5 PERCENT INCREASE YEAR-OVER-YEAR.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.54 EXCLUDING ITEMS.Q3 GAAP EARNINGS PER SHARE $1.25.Q3 EARNINGS PER SHARE VIEW $1.46 -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - CONTINUES TO EXPECT ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018 TO BE NEAR BOTTOM OF ITS GUIDANCE RANGE OF $6.45 TO $6.65.AMERISOURCEBERGEN - "AS AN UPDATE ON PHARMEDIUM, WE NOTIFIED THE FDA TWO WEEKS AGO THAT WE WERE RESUMING LIMITED PRODUCTION AT THE MEMPHIS FACILITY".AMERISOURCEBERGEN - "CONTINUE TO EXPECT PRODUCTION IN MEMPHIS TO INCREASE GRADUALLY OVER TIME AND BE FULLY OPERATIONAL IN FISCAL 2019".Q3 REVENUE VIEW $42.91 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $6.48 -- THOMSON REUTERS I/B/E/S.  Full Article

AmerisourceBergen Reports Q2 Earnings Per Share $1.29
Wednesday, 2 May 2018 

May 2 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $6.45 TO $6.65.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.94 EXCLUDING ITEMS.Q2 GAAP EARNINGS PER SHARE $1.29.Q2 EARNINGS PER SHARE VIEW $1.82 -- THOMSON REUTERS I/B/E/S.NOW BELIEVES ADJUSTED DILUTED EPS FOR FISCAL YEAR 2018 WILL BE AT BOTTOM OF ITS GUIDANCE RANGE OF $6.45 TO $6.65.SEES FISCAL YEAR 2018 REVENUE GROWTH IN RANGE OF 8 PERCENT TO 11 PERCENT ON AN ADJUSTED BASIS.REVENUES OF $41.0 BILLION FOR THE SECOND QUARTER, A 10.5 PERCENT INCREASE.Q2 REVENUE VIEW $40.64 BILLION -- THOMSON REUTERS I/B/E/S.SEES FISCAL YEAR 2018 ADJUSTED OPERATING INCOME GROWTH TO BE FLAT.FY2018 EARNINGS PER SHARE VIEW $6.53, REVENUE VIEW $167.48 BILLION -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - LOWER THAN PREVIOUSLY ANTICIPATED OPERATING INCOME CONTRIBUTIONS FROM PHARMEDIUM & LASH GROUP LED TO UPDATED FY 2018 GUIDANCE.  Full Article

AmerisourceBergen Anticipates Operations At Memphis Facility Will Resume This Quarter
Tuesday, 6 Feb 2018 

Feb 6 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN CORP CFO SAYS MEMPHIS FACILITY REMAINS CLOSED AND CURRENTLY ANTICIPATE OPERATIONS WILL RESUME THIS QUARTER - CONF CALL.AMERISOURCEBERGEN CORP CFO SAYS WE WERE PREVIOUSLY OPTIMISTIC THAT MEMPHIS OPERATIONS WOULD RESTART IN EARLY JANUARY - CONF CALL.AMERISOURCEBERGEN CORP CFO SAYS SEES 2018 PHARMACEUTICAL DISTRIBUTION SERVICES REVENUE GROWTH OF 1% TO 4%, REDUCED TO REFLECT IMPACT FROM PHARMEDIUM - CONF CALL.  Full Article

AmerisourceBergen Corp Says CEO Steven Collis' FY 2017 Total Compensation Was $9.9 Mln Vs $10.0 Mln In FY 2016
Friday, 19 Jan 2018 

Jan 19 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN CORP SAYS CEO STEVEN COLLIS' FY 2017 TOTAL COMPENSATION WAS $9.9 MILLION VERSUS $10.0 MILLION IN FY 2016 - SEC FILING.  Full Article

UPDATE 1-U.S. judge expresses support for novel opioid settlement talks framework

Aug 6 A federal judge on Tuesday expressed support for a novel plan by lawyers representing cities and counties suing drug companies over the U.S. opioid epidemic that would bring every community nationally into their settlement talks despite objections from most states.